Last reviewed · How we verify
Phenylephrine bolus 75 micrograms
Phenylephrine bolus 75 micrograms is a Small molecule drug developed by Rawalpindi Medical College. It is currently FDA-approved.
Phenylephrine is a small molecule adrenergic receptor alpha-1 agonist, classified as an agonist. It acts on the adrenergic receptor alpha-1 to produce its effects.
At a glance
| Generic name | Phenylephrine bolus 75 micrograms |
|---|---|
| Sponsor | Rawalpindi Medical College |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Phenylephrine bolus 75 micrograms CI brief — competitive landscape report
- Phenylephrine bolus 75 micrograms updates RSS · CI watch RSS
- Rawalpindi Medical College portfolio CI
Frequently asked questions about Phenylephrine bolus 75 micrograms
What is Phenylephrine bolus 75 micrograms?
Phenylephrine bolus 75 micrograms is a Small molecule drug developed by Rawalpindi Medical College.
Who makes Phenylephrine bolus 75 micrograms?
Phenylephrine bolus 75 micrograms is developed and marketed by Rawalpindi Medical College (see full Rawalpindi Medical College pipeline at /company/rawalpindi-medical-college).
What development phase is Phenylephrine bolus 75 micrograms in?
Phenylephrine bolus 75 micrograms is FDA-approved (marketed).
Related
- Manufacturer: Rawalpindi Medical College — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing